Home Financial Results

Financial Results

Piramal’s Pharma business grows over 10 % to 4,786 Crore in FY19

 The margins have improved from 10% in FY2011 to 23% in FY2019 Growth is attributed to revenues derived from niche businesses of complex generics and Contract Development and Manufacturing Operations (CDMO) Mumbai, July : Over 90% of Piramal's Pharma revenues derived...

Jubilant Life Sciences – Q4 & 12M’FY19 Results

  JUBILANT REPORTS RECORD PERFORMANCE IN FY'19 Revenue up 21% YoY to Rs. 9,111 Crore; EBITDA up 14% YoY to Rs 1,775 Crore Normalised PAT at Rs. 855 Crore with EPS at Rs. 54 per share Q4'FY19 Revenue at Rs 2,386...

Caredose registers 425% growth in the last quarter of FY 2018-19

To expand its services to five more cities apart from Delhi-NCR Targets expansion in South East Asia, Africa and Middle East by next year New Delhi, April 10, 2019: A MedTech start-up company, Caredose, announced today that it has...